A critical breakthrough in cancer research is emerging with the use of VHH fragments to re-engage mutated p53. This essential tumor inhibitor protein is frequently lost in several kinds of malignancies, resulting https://socialistener.com/story7410035/mini-antibodies-reactivate-tumor-suppressor-p53-new-promising-approach-for-malignant-management